Boston Scientific reports cyberattack disrupting global operations and order processing

Cyberattack Disrupts Boston Scientific Operations

Boston Scientific, a medical technology company, detected a cyberattack on August 25. The incident led to a network outage and affected access to certain operating systems and business applications. This disruption has impacted the company's ability to process and ship customer orders globally.

Operational Impact and Response

Following the detection of the intrusion, Boston Scientific activated its incident response procedures and engaged external cybersecurity experts to investigate and assist with containment. The company has stated that the timeline for a full restoration of all affected systems is not yet known. The ongoing disruption is expected to continue affecting the company's operations, including order fulfillment.

Company Profile and Market Significance

Boston Scientific is a major global manufacturer of medical devices, specializing in products for minimally invasive procedures such as stents, catheters, and pacemakers. With 59,000 employees, 13 manufacturing facilities, and a presence in 127 countries, the company reported over $20 billion in revenue in 2025. The disruption to such a large medical device supplier could have broader implications for healthcare providers and patients relying on its products.

Ongoing Investigation

The company's investigation into the cyberattack is ongoing to determine its nature, scope, and potential operational or financial consequences. Details regarding the type of attack, the perpetrator, initial access methods, or whether data was exposed or stolen have not been disclosed in the filing to the U.S. Securities and Exchange Commission (SEC).